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ABSTRACT
Background: Airway remodeling is a repair process occurring after airway injury; its primary histopathological
features are subepithelial fibrosis and smooth muscle thickening of the bronchi. These histopathological
changes are considered to occur due to bronchial smooth muscle cells (bSMC) that secrete extracellular matrix
(ECM) proteins, which work as chemoattractants and influence cell migration. Therefore, we examined the in-
teraction between bSMCs and ECM proteins in vitro for understanding the remodeling process in the bronchi.
Methods: bSMCs were cultured to collect a bSMC-conditioned medium. Using the bSMC-conditioned medium
thus obtained, we performed a cell migration assay, characterized β integrin expression, and identified ECM
proteins and matrix metalloproteinases by western blotting and gelatin zymography, respectively.
Results: The response of bSMC migration to bSMC-conditioned medium increased with time in culture, and fi-
bronectin (FIB) was detected as a chemoattractant for bSMCs in bSMC-conditioned medium by western blot
analysis and a cell migration assay using anti-FIB antibodies. The involvement of β1 integrin in the migration of
bSMCs toward FIB contained in bSMC-conditioned medium was demonstrated by inhibition of cell migration
using anti-β1 integrin antibodies. Expression of β1 integrin on bSMCs was confirmed by using a β-integrin-
mediated cell adhesion array. In addition, metalloproteinases detected in bSMC-conditioned medium by gelatin
zymography were suggested to be matrix metalloproteinase-1 and 2 by western blotting and amino acid se-
quencing.
Conclusions: Our results suggest that FIB and matrix metalloproteinases secreted from bSMCs might play
major roles in bSMC migration in the process of airway remodeling.
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Hanks’ balanced salt solution; hEGF, human epidermal growth factor; hFGF-B, human fibroblast growth factor-
basic; HPF, high power field; MMP, matrix metalloproteinase; MT-MMP, membrane-type matrix metalloprotein-
ase; PBS, phosphate buffered saline; PBST, PBS containing 0.1% Tween 20; PMSF, phenylmethylsulfonyl
fluoride; SDS, sodium dodecyl sulfate; SMC, smooth muscle cell; TIMP, tissue inhibitor of metalloproteinases;
uPA, urokinase plasminogen activator.
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INTRODUCTION
In chronic and severe asthma, persistent narrowing
occurs in the airway due to poorly reversible struc-
tural changes in the airway wall. These changes are
called “airway remodeling” and are associated with
epithelial injury and subsequent impaired healing.1
Despite advances in understanding the development
and progression of airway inflammation, there is rela-
tively little understanding of cellular and molecular
mechanisms underlying the structural changes ob-
served in such remodeling. The bronchi are located
in the lower regions of the airway and consist of epi-
thelium, basement membrane, connective tissue, and
smooth muscle, in succession from the lumen. Histo-
logical characteristics of the bronchial remodeling
comprise increases in smooth muscle mass and
subepithelial fibrosis accompanied by epithelial in-
jury.2 This remodeling process may be associated
with migration of smooth muscle cells (SMCs) into
connective tissue. It is known that intimal thickening
in the aortic wall caused by endothelial injury is
deeply involved with the migration of vascular SMCs;
moreover, their increased migration can lead to athe-
rosclerosis.3,4 Therefore, several investigators have
pointed out the potential role of the migration of
bronchial SMCs (bSMCs) in airway remodeling.5-7
However, it is still unclear whether the behavior of
bSMCs is similar to that of vascular SMCs in the
wound healing processes.
Johnson et al. measured the relative amounts of ex-
tracellular matrix (ECM) protein produced by
bSMCs in a medium with nonasthmatic serum and
identified a wide variety of ECM proteins, including
fibronectin (FIB), collagen type I, and laminin-β1, -γ1,
-β2, and -α1 chains.8 They reported that the amount
of FIB was greater than the amounts of collagen type
I and laminin chains. Furthermore, they determined
that the addition of asthmatic serum to the medium
caused a significant increase in the production of FIB
from bSMCs. In histological studies of asthmatic
bronchi, increased FIB was located in not only inter-
stitial and subepithelial connective tissues but also
smooth muscle.9 However, it is not clear whether FIB
secreted by bSMCs is involved in bSMC migration. It
has been shown that integrin β1 and β3 subunits are
involved in the migration of vascular SMCs stimu-
lated by FIB.10 As β1 and β3 integrins have been re-
ported to be expressed on bSMCs,11 these integrins
might play a role in bSMCs migration in response to
FIB produced by bSMCs.
The increase in ECM in the asthmatic airway could
be due to the following reasons: (i) increased de novo
synthesis of ECM proteins, (ii) decreased activity of
matrix metalloproteinases (MMPs), or (iii) upregula-
tion of tissue inhibitors of metalloproteinases
(TIMPs).12 MMP-1, 2, 3, 9, 10, and 12 as well as MT1-
MMP are expressed by airway SMCs.13-16 Further-
more, several studies on airway SMC migration have
suggested that the upregulation of MMP-2 and
membrane-type matrix metalloproteinases-1 (MT1-
MMP) are correlated with increased cell migration,17
and that MMP inhibitors reduce cell migration.18
In the present study, we investigated whether
bSMCs migrate in response to FIB in a bSMC-
conditioned medium via a mechanism involving their
own β integrins. Furthermore, we examined the pos-
sibility of the existence of MMPs in a bSMC-
conditioned medium.
METHODS
MATERIALS
Dulbecco’s modified Eagle medium (DMEM) and
Hanks’ balanced salt solution (HBSS) were pur-
chased from Life Technologies Corp., CA, USA. Bo-
vine serum albumin (BSA) and polyclonal anti-human
FIB (F3648), anti-human albumin (A0433), anti-
human MMP-1 (hinge region; M4177), and anti-
human MMP-2 antibodies (hinge region; M4677)
were obtained from Sigma-Aldrich Corp., MO, USA.
Monoclonal anti-human β1 integrin (IG6061) and
anti-human β3 integrin antibodies (IG6062) were
from Enzo Life Sciences International, PA, USA. All
other materials, unless specified otherwise, were ob-
tained from Wako Pure Chemical Industries, Osaka,
Japan.
CELL CULTURE
Human bSMCs were purchased from Lonza Walkers-
ville, MD, USA and cultured in SmGM-2 medium con-
taining 0.5 ngml human epidermal growth factor
(hEGF), 2 ngml human fibroblast growth factor-
basic (hFGF-B), 5 μgml insulin, 50 μgml gentami-
cin, 50 ngml amphotericin, and 5% fetal bovine se-
rum (FBS) (Lonza Walkersville). In brief, the cells
were seeded at a density of 2.8 × 104 cellsml in 100-
mm dishes and grown to a subconfluent density at
37℃ in 5% CO295% air. Then, the cells were washed
with 30 mmolL HEPES (Lonza Walkersville) and
harvested by treatment with 0.025% trypsin0.01%
EDTA (Lonza Walkersville). Subsequently, trypsin-
neutralizing solution (Lonza Walkersville) was added
to the cells, and they were centrifuged at 1,000 rpm
for 5 minutes. The pellet was then resuspended in the
same medium and reseeded in the same conditions.
The cells from the 5th-11th passages were used for the
following experiments.
COLLECTION OF CELL-CONDITIONED MEDIUM
We cultured bSMCs (2.8 × 104 cellsml) in SmGM-2
medium containing hEGF, hFGF-B, insulin, gentami-
cin, amphotericin, and 5% FBS to a confluent mono-
layer at 37℃ in 5% CO295% air. The confluent mono-
layer of bSMCs was washed twice with HBSS and
then cultured in DMEM without FBS for the indi-
cated times (0-72 hours) according to the method de-
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scribed by Shoji et al.19 The medium was collected at
0.1, 0.2, 0.3, 0.4, 0.5, 0.75, 1, 3, 6, 12, 24, 48, and 72
hours from the beginning of the culture in DMEM
and centrifuged at 2,000 rpm for 5 minutes. Each of
the supernatants was used as a bSMC-conditioned
medium for performing cell migration assay, gelatin
zymography, and western blotting.
CELL MIGRATION ASSAY
We measured bSMC migration toward bSMC-
conditioned medium using a modified Boyden cham-
ber assay.20 bSMC-conditioned medium or FIB was
placed in the lower compartment of a 48-well Boyden
chamber (Neuro Probe, MD, USA). DMEM was
used as a negative control. bSMC suspension (1.0 ×
106 cellsml in DMEM) was added to the upper com-
partment of the chamber. A polyvinylpyrrolidone-free
polycarbonate membrane with 8-μm pore size (What-
man plc, Kent, UK) was placed between the upper
and lower compartments. After 6-hours incubation at
37℃ in 5% CO295% air, the cells on the upper sur-
face of the membrane were removed by scraping, and
the cells that migrated through the membrane were
stained with Diff-QuikⓇ (Sysmex Corp., Hyogo, Ja-
pan) and counted in randomized 10 high-power fields
(10 HPF, 400× magnification) for each of the triplicate
membranes using a light microscope (Nikon Corp.,
Tokyo, Japan). Cell migration was expressed as the
number of migrated cells per 10 HPF in which the
background (DMEM: negative control) number of
migrating cells per 10 HPF was not subtracted from
the total number of migrating cells per 10 HPF.
QUANTITATIVE ASSAY FOR THE CHARACTERI-
ZATION OF β INTEGRIN EXPRESSION
The expression of β integrins on the surface of
bSMCs was determined using β integrin-mediated
cell adhesion array kit (CHEMICON International,
CA, USA). In brief, an aliquot (100 μl) of bSMCs
(1.0 × 106 cellsml in DMEM) were added to each
well of the array coated with various β integrin mono-
clonal antibodies through goat anti-mouse coating an-
tibodies. The negative control wells contained only
the coating antibodies. After incubation for 1 hour at
37℃ in 5% CO295% air, these wells were washed 3
times with the assay buffer (200 μl) from the kit.
bSMCs that were attached to the wells were stained
with a cell staining solution (100 μl) from the kit for 5
minutes at room temperature. Subsequently, bSMCs
were washed 4 times with deionized water, and
bSMC-bound dyes were completely solubilized by
the extraction buffer (100 μl) provided. The amount
of solubilized dyes was determined by the absor-
bance at 540 nm using ImmunoMini NJ2300 (Nalge
Nunc International Corp., NY, USA).
INHIBITION BY ANTI-FIB OR ANTI-INTEGRIN AN-
TIBODIES OF CELL MIGRATION TOWARD THE
CELL-CONDITIONED MEDIUM
To determine whether FIB in bSMC-conditioned me-
dium acts as a chemoattractant for bSMCs, bSMC-
conditioned medium was preincubated with anti-FIB
antibodies (25 μgml) for 1 hour at 37℃ and added to
the lower compartment of the Boyden chamber,
while the bSMC cell suspension (1.0 × 106 cellsml in
DMEM) was placed in the upper compartment of the
chamber.
Furthermore, to examine whether integrins are in-
volved in bSMC migration in response to bSMC-
conditioned medium, bSMC suspension (0.5 × 106
cellsml in DMEM) was preincubated with anti-β1 or
anti-β3 integrin antibodies (10 μgml) for 1 hour at
37℃ and placed in the upper compartment of the
Boyden chamber, while the bSMC-conditioned me-
dium was added to the lower compartment of the
chamber.
GELATIN ZYMOGRAPHY
The gelatinolytic activity of the bSMC-conditioned
medium was analyzed by gelatin zymography, ac-
cording to a modification of the method of Hibbs et
al.21 In brief, bSMC-conditioned medium was concen-
trated to one-fifth of its original volume and electro-
phoresed on sodium dodecyl sulfate (SDS)-
polyacrylamide gels (7.5%) containing 1 mgml gela-
tin. After electrophoresis, the gel was washed twice in
50 mM Tris-HCl (pH 7.6) containing 5 mM CaCl2 and
2.5% Triton X-100 for 30 minutes at room temperature
and incubated with the same buffer containing 5 mM
CaCl2 and 150 mM NaCl for 20 hours at 37℃. Then,
the gels were stained with 0.05% Coomassie brilliant
blue (CBB) and destained with 20% methanol in 10%
acetic acid, and the gelatinolytic activity was identi-
fied as transparent bands in the CBB-stained back-
ground. The molecular weights of the bands were es-
timated through the use of molecular-weight markers
(Daiichi Pure Chemicals Corp., Tokyo, Japan).
WESTERN BLOTTING
To identify FIB and MMPs in the bSMC-conditioned
medium, western blotting was performed. In brief,
the bSMC-conditioned medium was concentrated to
one-fifth or one-hundredth of its original volume for
FIB or MMPs detection, respectively, and electropho-
resed on SDS-polyacrylamide gels (7.5%). Bands on
the gel were transferred onto nitrocellulose mem-
branes using a semidry blotting apparatus (ATTO
Corp., Tokyo, Japan); then, the membranes were in-
cubated in blocking solution of phosphate buffered
saline (PBS) containing 0.1% Tween 20 and 2% BSA,
washed in 0.1% Tween 20PBS (PBST) and allowed
to react with anti-FIB, anti-MMP-1, and anti-MMP-2
polyclonal antibodies diluted at 1 : 1000, 1 : 20, and 1 :
20, respectively, in blocking solution for 1 hour at
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Fig. 1 Bronchial smooth muscle cel (bSMC) migration to-
ward bSMC-conditioned medium. Migrated bSMCs were 
counted in randomized 10 high-power fields (HPF, 400× 
magnification). bSMC-conditioned medium was colected at 
0.1, 0.2, 0.3, 0.4, 0.5, 0.75, 1, 3, 6, 12, 24, 48, and 72 hours 
after the beginning of the culture in serum-free Dulbecco’ s
modified Eagle medium (DMEM) and used for the migration 
assay. Background (DMEM: negative control) migration was 
2 cels per 10 HPF. Values are represented as mean ± SD 
(n = 3). Similar results were obtained in three independent 
experiments.
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Fig. 2 Analysis of fibronectin (FIB) in bSMC-conditioned 
medium by western bloting. bSMC-conditioned medium 
was obtained after 48-hours of incubation in serum-free 
DMEM, concentrated to one-fifth of its original volume, elec-
trophoresed on 7.5% SDS-polyacrylamide gels, and ana-
lyzed using anti-FIB polyclonal antibodies. Similar results 
were obtained in three independent experiments.
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Fig. 3 bSMC migration toward bSMC-conditioned medium 
treated with anti-FIB or anti-albumin antibodies. The concen-
tration of these antibodies was 25 μg/ml. bSMC-conditioned 
medium was obtained after 48-hours of incubation in serum-
free DMEM. Asterisk (*) indicates a significant diference 
from the value at bSMC-conditioned medium (P < 0.01, t-
test). Background (DMEM: negative control) migration was 
28 cels per 10 HPF. Values are represented as mean ± SD 
(n = 3). Similar results were obtained in three independent 
experiments.
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Fig. 4 Expression of β integrins on bSMCs. Aliquots (100 
μl) of bSMCs (1.0 × 106 cels/ml) were incubated at 37°C/5% 
CO2 in the aray of wels coated with various β integrin mono-
clonal antibodies. After incubation for 1 hour, bSMCs that at-
tached on the aray of wels were stained, and the dyes that 
bound to bSMCs were solubilized and determined by absor-
bance at 540 nm. Asterisk (*) indicates a significant difer-
ence from the value at negative control (goat anti-mouse 
antibodies only; P < 0.01, t-test). Values are represented as 
mean ± SD (n = 4).
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room temperature. After washing in PBST, the mem-
branes were incubated with horseradish peroxidase-
conjugated goat anti-rabbit antibodies (Jackson Im-
munoResearch Laboratories, PA, USA) diluted at 1 :
1000 or 1 : 160 in PBST for 1 hour at room tempera-
ture. After further washing with PBST, visualization
of the blots was achieved by incubating with 3,3’-
diaminobenzidine (Tokyo Chemical Industry Corp.,
Tokyo, Japan) in PBS containing 0.3% hydrogen per-
oxide.
N-TERMINAL AMINO ACID ANALYSIS
The bSMC-conditioned medium was concentrated to
one-five hundredth of its original volume and electro-
phoresed on SDS-polyacrylamide gels (7.5%). Bands
on the gel were transferred onto polyvinylidene
difluoride membranes using the semidry blotting ap-
paratus. After staining with Ponceau S, the corre-
sponding bands were excised and analyzed on a gas-
phase protein sequencer (Life Technologies Corp.,
CA, USA).
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Fig. 5 Migration of bSMCs treated with anti-β1 or anti-β3 
integrin antibodies toward bSMC-conditioned medium. The 
concentration of these antibodies was 7.5 μg/ml. bSMC-con-
ditioned medium was obtained after 48-hours of incubation 
in serum-free DMEM. Asterisk (*) indicates a significant dif-
ference from the value at bSMC-conditioned medium (P < 
0.01, t-test). Values are represented as mean ± SD (n = 3). 
Similar results were obtained in three independent 
experiments.
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Fig. 6 Analysis of proteases in bSMC-conditioned me-
dium by gelatin zymography. bSMC-conditioned medium 
was colected at 3, 6, 12, 24, 48, and 72 hours after the initia-
tion of culture in serum-free DMEM, concentrated to one-
fifth of its original volume, and electrophoresed on SDS-poly-
acrylamide gels (7.5%) containing 1 mg/ml gelatin. Bands 
with gelatinolytic activity were identified as transparent 
bands on the background of gels stained with Coomassie 
briliant blue (CBB, arows). Similar results were obtained in 
three independent experiments.
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Fig. 7 Classification of proteases in bSMC-conditioned 
medium by gelatin zymography using protease inhibitors. 
bSMC-conditioned medium was obtained after 48-hours of 
incubation in serum-free DMEM, concentrated to one-fifth of 
its original volume and applied on gelatin zymography in the 
absence (Lane 1) and presence of inhibitors: phenylmethyl-
sulfonyl fluoride (PMSF, Lane 2) and EDTA (Lane 3). Bands 
with gelatinolytic activity were identified as transparent 
bands on the background of the gels stained with CBB 
(arows). Similar results were obtained in three independent 
experiments.
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Fig. 8 Analysis of matrix metaloproteinases in bSMC-con-
ditioned medium by western bloting. bSMC-conditioned me-
dium was obtained after 48-hours of incubation in serum-
free DMEM, concentrated to one-hundredth of its original 
volume, electrophoresed on 7.5% SDS-polyacrylamide gels, 
and analyzed using anti-matrix metaloproteinase (MMP)-1 
(Lane 1) and anti-MMP-2 (Lane 2) polyclonal antibodies. 
Similar results were obtained in three independent 
experiments.
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STATISTICAL ANALYSIS
All results were obtained by at least three independ-
ent experiments and represented as mean ± SD. Sta-
tistical significance was evaluated using Student’s t-
test. A value of P < 0.01 was considered statistically
significant.
RESULTS
bSMC MIGRATION TOWARD bSMC-
CONDITIONED MEDIUM
The bSMC migration toward bSMC-conditioned me-
dium obtained at definite time intervals in culture is
shown in Figure 1. bSMC migration toward bSMC-
conditioned medium increased with time and, after 3
hours, reached a constant.
FIB AS A CHEMOATTRACTANT IN bSMC-
CONDITIONED MEDIUM
FIB was detected in a bSMC-conditioned medium in-
cubated for 48 hours in a serum-free medium by
western blotting as shown in Figure 2. To examine
whether FIB detected in the bSMC-conditioned me-
dium is a chemoattractant for bSMCs, a blocking ap-
proach by using anti-FIB antibodies was performed.
The concentration of the antibodies added to the
bSMC-conditioned medium was examined over a
range of 2.5-100 μgml; the optimal concentration
was determined to be 25 μgml because at this level,
the antibodies inhibited bSMC migration without
nonspecific binding. As shown in Figure 3, bSMC mi-
gration to the bSMC-conditioned medium was signifi-
cantly inhibited by pretreatment of the bSMC-
conditioned medium with anti-FIB antibodies at 25
μgml (P < 0.01) but not by pretreatment with anti-
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albumin antibodies at the same concentration.
IDENTIFICATION OFβ INTEGRINS ON bSMCS
The quantitative expression of β integrins on bSMC
was assayed using a β integrin-mediated cell adhe-
sion array. As shown in Figure 4, significant expres-
sion of β integrins such as β1 and β2 was identified
(P < 0.01), while the expression of β3, β4, and β6 in-
tegrins was not identified.
INVOLVEMENT OF β1 INTEGRIN IN bSMC MI-
GRATION
To examine the involvement of integrins in the migra-
tion of bSMCs induced by the bSMC-conditioned me-
dium, we performed blocking by anti-integrin anti-
bodies. The concentration of the antibodies added to
the bSMC-conditioned medium was examined over a
range of 1-10 μgml; the optimal concentration was
determined to be 7.5 μgml because at this level, the
antibodies inhibited bSMC migration without nonspe-
cific binding. As shown in Figure 5, preincubation of
bSMCs with anti-β1 integrin antibodies at 7.5 μgml
markedly abolished their ability to migrate in re-
sponse to the bSMC-conditioned medium (P < 0.01).
However, there was no influence on bSMC migration
following exposure of the bSMCs to anti-β3 integrin
antibodies.
GELATIN ZYMOGRAPHY FOR PROTEASE
ANALYSIS
The gelatinolytic activity in bSMC-conditioned me-
dium was analyzed by gelatin zymography. Figure 6
showed two major bands corresponding to 62 and 56
kDa and a minor band corresponding to 42 kDa. The
62-kDa band appeared as a strong active band in
bSMC-conditioned medium after 6-hours of incuba-
tion and enhanced with time, while the 56-kDa band
appeared as a moderate active band at 24 hours and
enhanced with time. The 42-kDa band appeared as a
fairly weak active band in bSMC-conditioned medium
incubated for 48 hours.
The effects of proteinase inhibitors on gelatinolytic
activities corresponding to the 42-, 56-, and 62-kDa
bands were shown in Figure 7. These activities were
inhibited by the metalloproteinase inhibitor, EDTA
(lane 3), but not by the serine protease inhibitor,
phenylmethylsulfonyl fluoride (PMSF, lane 2). These
results demonstrate that these 42-, 56-, and 62-kDa
proteases are metalloproteinases. Moreover, these
gelatinolytic activities were inhibited by another met-
alloproteinase inhibitor, 1,10-phenanthroline, but not
by another serine proteinase inhibitor, diisopropyl
fluorophosphate (DFP, data not shown).
WESTERN BLOT ANALYSIS FOR METALLO-
PROTEINASES
As shown in Figure 8, western blot analysis for metal-
loproteinases in bSMC-conditioned medium revealed
that three metalloproteinases corresponding to 42,
45, and 46 kDa and a metalloproteinase correspond-
ing to 56 kDa were detected by anti-MMP-1 (lane 1)
and anti-MMP-2 (lane 2) polyclonal antibodies, re-
spectively. From Figure 7, 8, it is clear that the 45-
and 46-kDa metalloproteinases detected by anti-
MMP-1 antibodies were gelatinolytically inactive in
this experimental system.
N-TERMINAL AMINO ACID SEQUENCING OF 62-
AND 56-kDa METALLOPROTEINASES
The N-terminal sequence of the metalloproteinase
corresponding to 56 kDa in the bSMC-conditioned
medium was Ala-Pro-Leu-Pro-Ile-Ile-Lys-Phe-Pro-Gly,
which had a high homology with residues 30-39 of
human MMP-2 (Ala-Pro-Ser-Pro-Ile-Ile-Lys-Phe-Pro-
Gly). Furthermore, the N-terminal sequence of the
metalloproteinase corresponding to 62 kDa in the
bSMC-conditioned medium was Ala-Pro-Leu-Pro and
in agreement with the N-terminal sequence of 56-kDa
metalloproteinase. The determination of only these
four amino acid sequences may be due to the fact
that the amount of 62-kDa metalloproteinase was too
small to perform amino acid sequence analysis, de-
spite the bSMC-conditioned medium being concen-
trated to one-five hundredth of its original volume.
DISCUSSION
In the present study, we suggested that FIB and
MMPs produced from bSMCs are involved in bSMC
migration involved in the process of airway remodel-
ing.
bSMCs were cultured to collect bSMC-conditioned
medium for up to 72 hours. As shown in Figure 1,
bSMC migration toward bSMC-conditioned medium
increased with time and, after 3 hours, reached a con-
stant. However, as given in Figure 6, proteinases cor-
responding to 42, 56, and 62 kDa were all detected in
the bSMC-conditioned medium cultured for 48 hours.
Therefore, we used the bSMC-conditioned medium
cultured for 48 hours in the present experiments.
First, FIB was detected as a chemoattractant in the
bSMC-conditioned medium that induced bSMC mi-
gration (Fig. 1-3). Two bands detected in Figure 2
may be derived by the cleavage of S-S bonds that as-
sociate two polypeptides to form the FIB molecule.
These two bands have also been detected in western
blot analysis of fibronectin synthesized by human
dermal fibroblasts.22
The expression of β1 and β2 integrins on bSMCs
was detected by the β integrin-mediated cell adhesion
array as shown in Figure 4. It was reported that in-
tegrins α1β1, α2β1, α3β1, α4β1, α5β1, αvβ1, and
αvβ3 that express on airway SMCs bind to fi-
bronectin.23 Freyer and others24 confirmed that α5,
αv, and β1 integrin subunits were universally ex-
pressed on airway SMCs, and that nearly half of iden-
tical cells were α6-positive. Less than one third of
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cells had detectable levels of α1, α3, and α4 integrins.
On the other hand, Nguyen and others25 reported
that subconfluent growth-arrested airway SMCs ex-
pressed low (<30%) levels of α1 and α6 integrins, in-
termediate (30-70%) levels of α4 and αv integrins, and
high (>70%) levels of α2, α5, β1 and β2 integrins. A
subpopulation of cells (～10%) expressed high levels
of α3, but in the remainder, the expression was low,
while β3 and β4 integrin expression was not detected.
We used ～70-80% confluent bSMCs for performing
the migration assay and the detection of integrins.
It is probable that the bSMCs used in this experi-
ment are synthetic phenotypes because of subculture
with trypsin treatment and serum stimulation. In ad-
dition, these bSMCs are derived from human fetal
lineages and preserved for shipments after 3 or 4 pas-
sages. It is speculated that transformed SMCs from
contractile to synthetic phenotype have high migra-
tory and proliferative activities, leading to diseases
with epithelium or endothelium injury such as
asthma and arteriosclerosis.
bSMC migration toward the bSMC-conditioned
medium was inhibited by pretreatment with anti-β1
integrin antibodies but not by anti-β3 integrin anti-
bodies (Fig. 5), suggesting that β3 integrin may not
contribute to bSMC migration induced by FIB in the
bSMC-conditioned medium because of its low expres-
sion. Present data also indicated that bSMC migra-
tion toward the bSMC-conditioned medium was in-
hibited almost completely by pretreatment with anti-
β1 integrin antibodies; however,～70% inhibition was
noted following pretreatment with anti-FIB antibod-
ies. These facts suggest that chemoattractants other
than FIB, which are recognized by β1 integrin, may
be present in the bSMC-conditioned medium. Since it
has been reported that β1 integrin recognizes not
only FIB but collagen type I and laminin as well,23 the
detection of collagen type I and laminin in bSMCs-
conditioned medium were attempted by western blot-
ting. However, there was little or no detection of
these chemoattractants in the bSMC-conditioned me-
dium (data not shown). It has been demonstrated
that airway SMC migration is elicited by IL-1β, IL-8,
and PDGF-BB.26,27 As IL-1β, IL-8, and PDGF-BB are
expressed by airway SMCs,16 these immunomodula-
tory molecules might be present in the bSMC-
conditioned medium.
FAK and p4244 MAPK are known to be involved
in vascular SMC migration stimulated by FIB.28 p42
44 MAPK, Rho, and p38 signals have been shown to
be crucial for airway SMC migration by urokinase
plasminogen activator (uPA).29 These signal mole-
cules may play an important role in bSMC migration
toward bSMC-derived FIB.
Proteinases corresponding to 42, 56, and 62 kDa
detected in the bSMC-conditioned medium were de-
termined to be metalloproteinases (Fig. 7), and anti-
MMP-1 and anti-MMP-2 antibodies recognized the
42- and 56-kDa metalloproteinases, respectively (Fig.
8). However, these antibodies did not recognize the
62-kDa metalloproteinase, despite the bSMC-
conditioned medium being highly concentrated. This
strongly active 62-kDa metalloproteinase might also
be MMP-2, the amount of which was lesser than that
of the 56-kDa metalloproteinase in the bSMC-
conditioned medium. It is known that MMP-2 is acti-
vated by autolysis at a rate that is concentration-
dependent, processing not only the N-terminal do-
main but also the C-terminal domain.30,31 Atkinson et
al. reported that human proMMP-2 was partially
cleaved by the cell membrane to yield the 59-kDa
form via the 62-kDa form, but they were unable to de-
termine the precise cleavage site.32 Lindstad et al.
showed that trypsin-mediated activation of human
proMMP-2 resulted in the formation of 62-, 56-, 52-,
and 50-kDa forms.33 In addition, they suggested that
the 62-kDa form was generated by truncating the N-
terminal propeptide domain of 72-kDa proMMP-2;
subsequently, 56-, 52- and 50-kDa forms were gener-
ated by truncating the C-terminal hemopexin domain
of the 62-kDa form. However, our study proposes that
the 62- and 56-kDa metalloproteinases contained in
the bSMC-conditioned medium might be due to 10-
and 16-kDa cleavages in the hemopexin domain of
proMMP-2, respectively.
This proposal was verified by western blotting us-
ing antibodies that recognize the propeptide domain
of MMP-2 (M5928, Sigma) and by N-terminal amino
acid sequencing of both 56- and 62-kDa metalloprote-
inases. In western blotting analysis of the bSMC-
conditioned medium, the 56-kDa metalloproteinase
was immunoreactive for anti-MMP-2 antibodies that
recognize a hinge region located between the cata-
lytic and C-terminal hemopexin domains (Fig. 8).
Furthermore, this 56-kDa metalloproteinase was im-
munoreacted with anti-MMP-2 antibodies that recog-
nize the propeptide domain (data not shown). In the
analysis of N-terminal amino acid sequences, the 56-
and 62-kDa metalloproteinases in the highly concen-
trated bSMC-conditioned medium were compared
with that of human MMP-2 in a public database
(NCBI P08253). The N-terminal sequence of 10
amino acid residues of the 56-kDa metalloproteinase
was in fair agreement with residues 30-39 of human
MMP-2. Moreover, the N-terminal sequence analysis
of the 62-kDa metalloproteinase exactly coincided
with that of 56-kDa metalloproteinase.
The disagreement between the N-terminal se-
quences of these two metalloproteinases and resi-
dues 30-39 within human MMP-2 was observed at
residue 32, where Ser was replaced by Leu. This dis-
agreement of MMP-2 might be induced by a genetic
mutation. Ser32 within human MMP-2 is encoded by
the DNA sequence TCG (405-407, NCBI NM_
004530.4) whereas Leu is encoded by TTG. It is
known that a G=C→ A=T point mutation in the DNA
Nishihara-Fujihara M et al.
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molecule is the most frequent one in human cells and
cancer.34,35
It has been reported that cell adhesion to fi-
bronectin through integrin induces the production of
MMP-2 as well as the downregulation of TIMP-2.36
This finding also suggests that the adhesion to fi-
bronectin transduced both stimulatory (through Src-
type tyrosine kinases) and inhibitory signals
(through RasMAPKinase signaling pathways) for
MMP-2 expression and that their relative predomi-
nance was regulated by additional stimuli related to
cell adhesion, motility, and growth.
These findings suggest that FIB and metalloprote-
inases containing MMPs-1 and 2 produced from
bSMCs lead to the stimulation of bSMC migration,
implying that this behavior may be an important proc-
ess in airway remodeling in asthma. Suppression of
bSMC migration by a β1 integrin antagonist or MMP-
1 and -2 inhibitors might offer a new therapeutic di-
rection against bronchial remodeling in asthma.
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